Beyond Air, Inc. Derivative, Fair Value, Net
Beyond Air, Inc. (XAIR) had Derivative, Fair Value, Net of $0 as of 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Notes › Derivative Instruments and Hedging Activities
us-gaap:DerivativeFairValueOfDerivativeNet · last filed 2024-11-12
- 2024-09-30: Derivative, Fair Value, Net $0.00.
| Period end | Derivative, Fair Value, Net |
|---|---|
| 2024-09-30 | $0.00 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |